Mankind Pharma Reports 11.5% Revenue Growth in Q3 FY26
New Delhi: Mankind Pharma has reported a 11.5 per cent year-on-year rise in consolidated revenue for the third quarter ended December 31, 2025, supported by steady domestic formulation growth, strong…